FHIR © HL7.org  |  FHIRsmith 4.0.1  |  Server Home  |  XIG Home  |  XIG Stats  | 

FHIR IG analytics

Resources - All Kinds, Realm US, Authority Hl7

19,367 resources (JSON | CSV)

Type:
Text: Package: Only Show Used

By Version

 

Start Prev Rows 12200 - 12400 Next

PackageVersionIdentityName/TitleStatusFMMWGDateUsage #
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.232.jsonWarfarinactive2021-021
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.234.jsonHemorrhagic Strokeactive2021-022
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.235.jsonHemorrhagic Strokeactive2021-022
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.238.jsonCarotid Interventionactive2025-011
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.239.jsonCarotid Interventionactive2019-031
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.242.jsonAtrial Ablationactive2025-021
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.243.jsonAtrial Ablationactive2025-021
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.244.jsonAtrial Fibrillation or Flutteractive2021-02
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.245.jsonAtrial Fibrillation or Flutteractive2021-021
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.246.jsonAtrial Fibrillation or Flutteractive2025-021
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.247.jsonIschemic Strokeactive2021-02
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.25.jsonSingle Live Birthactive2021-061
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.251.jsonIschemic Stroke Embolismactive2021-022
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.252.jsonIschemic Stroke Embolismactive2021-022
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.255.jsonGeneral Surgeryactive2022-03
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.256.jsonGraduated compression stockingsactive2024-02
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.257.jsonGynecological Surgeryactive2022-03
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.258.jsonHip Fracture Surgeryactive2022-03
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.259.jsonHip Replacement Surgeryactive2022-03
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.26.jsonSingle Live Born Newborn Born in Hospitalactive2021-06
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.260.jsonIntracranial Neurosurgeryactive2022-03
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.261.jsonKnee Replacement Surgeryactive2022-03
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.263.jsonObstetrical or Pregnancy Related Conditionsactive2022-03
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.264.jsonObstetrics VTEactive2022-03
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.27.jsonDietary Intake Other than Human Milkactive2021-02
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.270.jsonAcute or Persistent Asthmaactive2022-011
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.271.jsonAcute or Persistent Asthmaactive2022-01
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.272.jsonUrological Surgeryactive2022-03
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.279.jsonVenous Thromboembolismactive2022-03
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.281.jsonLaboractive2021-06
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.282.jsonCesarean Birthactive2022-03
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.286.jsonConditions Possibly Justifying Elective Delivery Prior to 39 Weeks Gestationactive2021-06
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.288.jsonMedical Induction of Laboractive2022-03
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.292.jsonEmergency Department Visitactive2021-062
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.294.jsonDecision to Admit to Hospital Inpatientactive2021-021
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.295.jsonDecision to Admit to Hospital Inpatientactive2022-03
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.296.jsonPsychiatric/Mental Health Diagnosisactive2024-021
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.298.jsonPsychiatric/Mental Health Diagnosisactive2024-021
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.299.jsonPsychiatric/Mental Health Diagnosisactive2022-03
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.30.jsonHuman Milkactive2025-05
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.308.jsonLeft Against Medical Adviceactive2021-02
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.309.jsonPatient Expiredactive2021-06
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.310.jsonGynecological Surgeryactive2024-021
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.313.jsonGynecological Surgeryactive2023-011
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.315.jsonKnee Replacement Surgeryactive2025-021
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.317.jsonKnee Replacement Surgeryactive2023-021
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.319.jsonHip Replacement Surgeryactive2025-021
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.321.jsonHip Replacement Surgeryactive2024-021
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.323.jsonHip Fracture Surgeryactive2025-021
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.325.jsonHip Fracture Surgeryactive2025-021
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.328.jsonVenous Thromboembolismactive2025-021
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.33.jsonGalactosemiaactive2024-041
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.330.jsonVenous Thromboembolismactive2025-021
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.331.jsonUrological Surgeryactive2024-021
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.333.jsonUrological Surgeryactive2025-021
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.335.jsonObstetrical or Pregnancy Related Conditionsactive2024-022
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.337.jsonObstetrical or Pregnancy Related Conditionsactive2025-022
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.338.jsonObstetrics VTEactive2021-022
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.340.jsonObstetrics VTEactive2024-022
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.344.jsonIntracranial Neurosurgeryactive2021-022
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.346.jsonIntracranial Neurosurgeryactive2025-022
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.348.jsonGeneral or Neuraxial Anesthesiaactive2021-021
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.35.jsonGalactosemiaactive2021-02
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.361.jsonGeneral Surgeryactive2021-041
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.365.jsonGeneral Surgeryactive2025-021
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.367.jsonCesarean Birthactive2021-061
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.369.jsonCesarean Birthactive2025-021
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.37.jsonParenteral Nutritionactive2021-021
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.38.jsonParenteral Nutritionactive2022-03
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.384.jsonMedical Induction of Laboractive2024-041
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.393.jsonConditions Possibly Justifying Elective Delivery Prior to 39 Weeks Gestationactive2024-041
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.395.jsonConditions Possibly Justifying Elective Delivery Prior to 39 Weeks Gestationactive2025-051
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.400.jsonLow Riskactive2024-02
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.401.jsonDelivery Proceduresactive2025-021
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.418.jsonClassical Cesarean Birthactive2024-041
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.419.jsonClassical Cesarean Birthactive2021-061
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.421.jsonClassical Cesarean Birthactive2022-03
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.422.jsonMyomectomyactive2024-04
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.423.jsonStatin Allergenactive2021-022
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.424.jsonNonelective Inpatient Encounteractive2025-02
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.473.jsonMedical Reason For Not Providing Treatmentactive2022-02
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.75.jsonNeonatal Intensive Care Unitactive2021-021
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.76.jsonSingle Live born Newbornactive2021-061
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.78.jsonGalactosemiaactive2021-021
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.79.jsonParenteral Nutritionactive2021-021
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.87.jsonDischarge To Acute Care Facilityactive2021-06
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.93.jsonPatient Refusalactive2025-02
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.1434.1047.jsonSkin Melanoma pT1active2024-10
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.100.jsonInjectable Fluorouracilactive2020-093
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.101.jsonTrastuzumab and Biosimilarsactive2023-071
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.102.jsonBreast Canceractive2020-101
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.103.jsonHER2 Presence in Tissueactive2020-091
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.104.jsonDepression Screening for Adultactive2020-101
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.105.jsonLong Acting Opioidsactive2024-081
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.106.jsonHigh Fiber Supplement or Diet Educationactive2020-101
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.107.jsonStandardized Assessment Tools for Dyspneaactive2020-101
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.108.jsonNausea or Vomiting Assessmentactive2020-101
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.109.jsonPancreatic Canceractive2020-101
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.110.jsonPancreatic Canceractive2023-071
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.111.jsonAudio Visual Telehealth Encounteractive2020-101
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.112.jsonTelephone Encounteractive2020-101
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.113.jsonTelehealth Emergency Department or Initial Inpatientactive2020-101
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.114.jsonKarnofsky Performance Statusactive2020-101
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.115.jsonReferral to Hospice Careactive2020-101
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.116.jsonReferral to Palliative Careactive2020-101
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.117.jsonAssessment Scale for Dyspneaactive2020-101
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.118.jsonNausea or Vomiting Assessmentactive2020-101
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.119.jsonEnrollment in Hospice Careactive2020-101
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.120.jsonPalliative Careactive2020-101
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.121.jsonAdvance Directive Including Durable Power of Attorney or Instructionalactive2020-101
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.122.jsonCarmustine Injectableactive2022-09
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.123.jsonDacarbazine Injectableactive2021-03
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.124.jsonStreptozocin Injectableactive2021-03
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.126.jsonAlemtuzumab Injectableactive2024-11
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.127.jsonAzacitidine Injectableactive2024-11
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.128.jsonBendamustine Injectableactive2024-11
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.129.jsonBusulfan Injectableactive2021-03
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.130.jsonTemozolomide Injectableactive2021-03
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.131.jsonThiotepa Injectableactive2021-03
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.132.jsonOxaliplatin Injectableactive2021-032
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.133.jsonRomidepsin Injectableactive2021-03
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.134.jsonTrabectedin Injectableactive2021-03
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.135.jsonDolasetron Oralactive2021-032
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.136.jsonDolasetron Injectableactive2025-04
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.137.jsonGranisetron Oralactive2021-032
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.138.jsonGranisetron Transdermalactive2021-032
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.139.jsonGranisetron Injectableactive2021-032
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.140.jsonOndansetron Oralactive2021-032
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.141.jsonOndansetron Injectableactive2021-032
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.142.jsonIfosfamide Injectableactive2021-03
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.143.jsonArsenic Trioxide Injectableactive2024-11
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.144.jsonNetupitant Palonosetron Oralactive2021-032
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.145.jsonFosnetupitant Palonosetron Injectableactive2021-032
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.146.jsonAprepitant Injectableactive2024-112
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.147.jsonRolapitant Injectableactive2021-032
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.148.jsonDexamethasone Oralactive2022-092
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.149.jsonDexamethasone Injectableactive2021-032
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.150.jsonDexamethasone Drug Implantactive2025-042
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.151.jsonOlanzapine Oralactive2021-032
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.152.jsonOlanzapine Injectableactive2021-032
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.153.jsonIdarubicin Injectableactive2024-112
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.154.jsonNeurokinin 1 Receptor Antagonist Ingredientactive2021-03
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.155.jsonSerotonin Receptor Antagonist Ingredientactive2021-03
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.156.jsonClofarabine Injectableactive2021-03
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.157.jsonBelinostat Injectableactive2024-111
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.158.jsonBortezomib Injectableactive2024-111
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.159.jsonCabazitaxel Injectableactive2021-051
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.160.jsonCarfilzomib Injectableactive2021-051
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.161.jsonDecitabine Injectableactive2021-051
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.162.jsonElotuzumab Injectableactive2021-051
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.163.jsonEnfortumab Injectableactive2021-051
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.164.jsonEribulin Injectableactive2021-051
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.165.jsonEtoposide Injectableactive2021-051
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.166.jsonInotuzumab Ozogamicin Injectableactive2021-051
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.167.jsonMitoxantrone Injectableactive2024-112
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.168.jsonMoxetumomab Injectableactive2021-051
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.169.jsonNecitumumab Injectableactive2021-051
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.170.jsonNelarabine Injectableactive2021-051
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.171.jsonTemsirolimus Injectableactive2021-051
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.172.jsonTisagenlecleucel Injectableactive2021-051
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.173.jsonTopotecan Injectableactive2021-051
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.178.jsonAtezolizumab Injectableactive2024-111
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.179.jsonAvelumab Injectableactive2024-111
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.180.jsonBleomycin Injectableactive2024-111
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.181.jsonCemiplimab Injectableactive2024-111
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.182.jsonCladribine Injectableactive2021-051
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.183.jsonDaratumumab Injectableactive2025-041
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.184.jsonDurvalumab Injectableactive2024-111
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.185.jsonEmapalumab Injectableactive2024-111
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.186.jsonFludarabine Injectableactive2021-051
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.187.jsonIpilimumab Injectableactive2024-112
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.188.jsonNivolumab Injectableactive2024-112
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.189.jsonPembrolizumab Injectableactive2024-122
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.190.jsonPolatuzumab Vedotin Injectableactive2021-071
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.191.jsonPralatrexate Injectableactive2021-071
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.192.jsonVincristine Injectableactive2021-071
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.193.jsonMethotrexate Injectableactive2025-041
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.194.jsonTrastuzumab Injectableactive2025-041
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.195.jsonMitomycin Injectableactive2021-051
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.196.jsonBrentuximab Vedotin Injectableactive2021-051
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.197.jsonDoxorubicin Pegylated Liposomal Injectableactive2024-112
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.198.jsonBlinatumomab Injectableactive2024-111
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.199.jsonTrastuzumab Emtansine Injectableactive2021-051
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.200.jsonGemtuzumab Ozogamicin Injectableactive2021-051
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.201.jsonTagraxofusp Injectableactive2024-121
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.202.jsonAxicabtagene Ciloleucel Injectableactive2024-111
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.203.jsonBRCA1active2023-06
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.204.jsonBRCA2active2023-06
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.205.jsonBRCA1 Testingactive2023-061
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.207.jsonEpithelial Ovarian Canceractive2024-081
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.208.jsonPrimary Peritoneal Canceractive2022-061
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.209.jsonFallopian Tube Canceractive2022-061
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.210.jsonMultigene Panelactive2023-071
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.211.jsonBRCA1 and BRCA2active2023-06
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.212.jsonBRCA1 and BRCA2 Testingactive2023-06
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.213.jsonBRAF V600active2022-01
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.214.jsonBRAF V600 Testingactive2023-041
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.215.jsonColorectal Canceractive2024-081
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.216.jsonBRAF V600 Mutation Statusactive2022-01
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.217.jsonCancer Stage Iactive2024-08